November 2024

Study, in patients with solid tumors focusing on gynecological malignant tumors such as ovarian, endometrial, and cervical, nearing completion with three remaining subjects to be enrolled 27% Objective Response Rate (ORR) 33% Clinical Benefit Rate (CBR) with a median Progression Free Survival (PFS)

HAUPPAUGE, N.Y., Nov. 11, 2024 /PRNewswire/ — Walker’s Shortbread, a beloved Scottish brand with deep roots in tradition and innovation, is celebrating a significant milestone in its U.S. growth story. Sir Jim Walker, CBE, was awarded the prestigious 2024 Wallace Award by the American Sc

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: